Literature DB >> 29361307

Renal tubule injury: a driving force toward chronic kidney disease.

Bi-Cheng Liu1, Tao-Tao Tang2, Lin-Li Lv2, Hui-Yao Lan3.   

Abstract

Renal tubules are the major component of the kidney and are vulnerable to a variety of injuries including hypoxia, proteinuria, toxins, metabolic disorders, and senescence. It has long been believed that tubules are the victim of injury. In this review, we shift this concept to renal tubules as a driving force in the progression of kidney diseases. In response to injury, tubular epithelial cells undergo changes and function as inflammatory and fibrogenic cells, with the consequent production of various bioactive molecules that drive interstitial inflammation and fibrosis. Innate immune-sensing receptors on the tubular epithelium also aggravate immune responses. Necroinflammation, an autoamplification loop between tubular cell death and interstitial inflammation, leads to the exacerbation of renal injury. Furthermore, tubular cells also play an active role in progressive renal injury via emerging mechanisms associated with a partial epithelial-mesenchymal transition, cell-cycle arrest at both G1/S and G2/M check points, and metabolic disorder. Thus, a better understanding the mechanisms by which tubular injury drives inflammation and fibrosis is necessary for the development of therapeutics to halt the progression of chronic kidney disease.
Copyright © 2017 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  acute kidney injury; chronic kidney disease; renal fibrosis; renal inflammation; renal tubule

Mesh:

Substances:

Year:  2018        PMID: 29361307     DOI: 10.1016/j.kint.2017.09.033

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  164 in total

1.  Glycolysis inhibitors suppress renal interstitial fibrosis via divergent effects on fibroblasts and tubular cells.

Authors:  Qingqing Wei; Jennifer Su; Guie Dong; Ming Zhang; Yuqing Huo; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2019-04-10

Review 2.  Ferroptosis and kidney diseases.

Authors:  Shumei Tang; Xiangcheng Xiao
Journal:  Int Urol Nephrol       Date:  2019-11-25       Impact factor: 2.370

Review 3.  Drug-induced tubulointerstitial nephritis: hypersensitivity and necroinflammatory pathways.

Authors:  Allison A Eddy
Journal:  Pediatr Nephrol       Date:  2019-02-28       Impact factor: 3.714

4.  Examining Local Cell-to-Cell Signalling in the Kidney Using ATP Biosensing.

Authors:  Gareth W Price; Joe A Potter; Bethany M Williams; Chelsy L Cliff; Mark J Wall; Claire E Hills; Paul E Squires
Journal:  Methods Mol Biol       Date:  2021

5.  Mechanisms of Scarring in Focal Segmental Glomerulosclerosis.

Authors:  Jianyong Zhong; Jacob B Whitman; Hai-Chun Yang; Agnes B Fogo
Journal:  J Histochem Cytochem       Date:  2019-05-22       Impact factor: 2.479

Review 6.  Proximal Tubular Transcription Factors in Acute Kidney Injury: Recent Advances.

Authors:  Sian E Piret; Sandeep K Mallipattu
Journal:  Nephron       Date:  2020-07-09       Impact factor: 2.847

7.  Claudin-2 suppresses GEF-H1, RHOA, and MRTF, thereby impacting proliferation and profibrotic phenotype of tubular cells.

Authors:  Qinghong Dan; Yixuan Shi; Razieh Rabani; Shruthi Venugopal; Jenny Xiao; Shaista Anwer; Mei Ding; Pam Speight; Wanling Pan; R Todd Alexander; András Kapus; Katalin Szászi
Journal:  J Biol Chem       Date:  2019-09-03       Impact factor: 5.157

8.  Dickkopf-3 (DKK3) in Urine Identifies Patients with Short-Term Risk of eGFR Loss.

Authors:  Stephen Zewinger; Thomas Rauen; Michael Rudnicki; Giuseppina Federico; Martina Wagner; Sarah Triem; Stefan J Schunk; Ioannis Petrakis; David Schmit; Stefan Wagenpfeil; Gunnar H Heine; Gert Mayer; Jürgen Floege; Danilo Fliser; Hermann-Josef Gröne; Thimoteus Speer
Journal:  J Am Soc Nephrol       Date:  2018-10-02       Impact factor: 10.121

9.  Differential kidney proximal tubule cell responses to protein overload by albumin and its ligands.

Authors:  Kimberly R Long; Youssef Rbaibi; Megan L Gliozzi; Qidong Ren; Ora A Weisz
Journal:  Am J Physiol Renal Physiol       Date:  2020-02-18

10.  Tenascin-C promotes acute kidney injury to chronic kidney disease progression by impairing tubular integrity via αvβ6 integrin signaling.

Authors:  Haili Zhu; Jinlin Liao; Xianke Zhou; Xue Hong; Dongyan Song; Fan Fan Hou; Youhua Liu; Haiyan Fu
Journal:  Kidney Int       Date:  2020-02-17       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.